Lite Strategy Reports First Quarter Fiscal Year 2026 Results; Highlights Successful Launch of $100M Litecoin Treasury Strategy and Movement into Active Capital Market Operations

Core Viewpoint - Lite Strategy, Inc. has transitioned from MEI Pharma to focus on adopting Litecoin as its primary reserve asset, marking a significant shift in its corporate strategy and positioning itself as a leader in digital asset treasury management [2][9]. Group 1: Corporate Strategy and Developments - The company announced a $25 million share repurchase program, which allows it to leverage its nearly 1 million LTC treasury, differentiating itself from passive investment structures like exchange-traded funds [1]. - Lite Strategy officially became the first U.S.-listed public company to adopt Litecoin as a primary reserve asset by acquiring 929,548 LTC tokens, implementing a new strategy based on digital asset infrastructure [3]. - The rebranding from MEI Pharma to Lite Strategy, including a new corporate name and NASDAQ ticker (from MEIP to LITS), emphasizes the company's commitment to a long-term strategy centered around Litecoin [2]. Group 2: Financial Performance and Future Outlook - The company reported a successful first quarter for fiscal year 2026, launching its digital treasury strategy and positioning itself as the leading public holder of LTC [5]. - As of September 30, 2025, Lite Strategy had $12.21 million in working capital with no outstanding debt, indicating a strong financial position [6]. - The CEO highlighted that fiscal year 2026 will showcase the results of transformative steps taken, including the sale of clinical assets and the initiation of a $100 million PIPE offering to support the Litecoin digital asset treasury strategy [4].